Pacific northwest bioMedical Innovation Co-Laboratory (PMedIC)


Individual differences in genes and proteins can allow a disease to develop, grow, and spread in one person but not another, and also dictate how individuals respond to treatments. Oregon Health & Science University and the U.S. Department of Energy's Pacific Northwest National Laboratory launched the Precision Medicine Innovation Co-Laboratory in February 2018 to integrate patient-specific differences in diagnosis and clinical care. The scope of the joint venture was expanded to include basic science research programs and it was renamed the Pacific northwest bioMedical Innovation Co-laboratory (PMedIC) in January 2022. PMedIC aims to generate, interpret, and integrate multidimensional omics and imaging data with clinical results to gain mechanistic understanding of disease and develop innovative therapies.

PMedIC leadership act as a clearinghouse for researchers, matching them to subject matter experts at both OHSU and PNNL. They also assist in putting together teams for the development of joint proposals, help investigators identify sources of funding for pilot projects, and assist with proposal management.

New insights from PMedIC's approach will inform clinical trials, leading to more customized treatments and better patient outcomes.



Bobbie-Jo Webb-Robertson image

Bobbie-Jo Webb-Robertson, Ph.D.
PNNL Co-Director
Director of Biomedical Research Partnerships
Pacific Northwest National Laboratory

Bobbie-Jo Webb-Robertson has 20 years of experience in statistics and data science. She currently serves as the chief scientist of computational biology in the Biological Sciences Division at PNNL. Her research portfolio is largely related to the biomedical field and primarily focuses on the development and application of advanced statistical and machine learning methods to address challenges associated with large and complex omics data, as well as integration across multiple data sources.

Beth Habecker image

Beth Habecker, Ph.D.
OHSU Co-Director
Professor of Chemical Physiology and Biochemistry, School of Medicine
Oregon Health & Science University

Beth Habecker is biomedical scientist investigating injury-induced neural plasticity and on the role of sympathetic nerves in triggering cardiac arrhythmias and modulating immune responses. She has been a faculty member at OHSU for nearly 25 years, serving as a leader in both research and education. She is currently Professor of Chemical Physiology & Biochemistry, with additional appointments in Anesthesiology & Perioperative Medicine and the Department of Medicine, Division of Cardiovascular Medicine.

PMedIC Co-Director Dr. Karin Rodland talks about the promise of precision medicine: "I dream of a day when no one has to die because of cancer."

Hear how OHSU's Knight Cancer Institute is personalizing medicine for its patients.

Dr. Karin Rodland talks about identifying the proteins in ovarian tumors—the first step to targeting drugs for specific individuals.

Meet the scientists of OHSU.